Blood glucose monitoring device market seen reaching $30.43B by 2030

The global market for blood glucose monitoring devices is projected to climb from $19.08 billion in 2025 to $30.43 billion by 2030, driven by rising diabetes rates, obesity, and wider adoption of continuous monitoring and home care. North America led the market in 2025, while Asia-Pacific is forecast to grow fastest.

Why it matters: - Blood glucose monitoring devices are central to diabetes care because they help patients and clinicians track blood sugar, adjust treatment and reduce complications. - The market’s projected rise to $30.43 billion by 2030 signals sustained demand for tools that support chronic disease management, home care and preventive health.

What happened: - The Business Research Company projected the blood glucose monitoring devices market will grow from $19.08 billion in 2025 to $21.02 billion in 2026. - The report forecasts the market will reach $30.43 billion by 2030. - The 2025-2026 period reflects a 10.1% compound annual growth rate, while the 2026-2030 period is forecast at 9.7%. - The report was published from London on Oct. 15, 2026.

The details: - Rising diabetes prevalence remains the main growth driver, alongside an aging population, higher healthcare spending, better access to diagnostic technology and greater awareness of diabetes management. - Future demand is expected to come from continuous glucose monitoring systems, broader use of home healthcare, stronger preventive care efforts, improved reimbursement for diabetes treatment and rising obesity-linked metabolic disorders. - The report defines blood glucose monitoring devices as medical tools used to measure and track blood sugar levels in people with diabetes and other metabolic conditions. - These devices support treatment decisions by showing glucose fluctuations and helping maintain glycemic control. - The UK Health Security Agency reported in March 2025 that GP-recorded prevalence of type 2 diabetes in England among adults 17 and older rose from 6.8% in March 2023 to 7.0% in March 2024. - That increase equals roughly 2.9% growth in recorded prevalence. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The forecast points to a market moving beyond basic glucose testing toward continuous monitoring and broader care integration. - Reimbursement policy and home-care adoption could matter as much as device innovation because both shape how quickly patients can access these products. - North America held the largest market share in 2025, but the fastest growth is expected in Asia-Pacific, suggesting the next phase of expansion will be increasingly global. - The report’s added features, including TAM analysis, company scoring matrices and market hotspot dashboards, indicate a heavier focus on buyer intelligence and competitive positioning.

What's next: - The Business Research Company expects demand to keep rising through 2030 as diabetes and obesity rates continue to increase. - Market growth will likely track adoption of continuous glucose monitoring, home healthcare services and reimbursement improvements. - The Asia-Pacific region is expected to deliver the strongest regional growth in the coming years.

The bottom line: - Blood glucose monitoring is shifting from a niche diagnostic category to a core chronic-care market, and that makes the sector one to watch through the end of the decade.